Status: current, Defined. Date: 31-Mar 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4536251000168115 | Abrilada (adalimumab 40 mg / 0.8 mL) injection, 1 x 0.8 mL pen device (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4536261000168118 | Abrilada 40 mg/0.8 mL injection, 0.8 mL pen device | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Abrilada 40 mg/0.8 mL injection, 0.8 mL pen device | Is a | trade product pack | true | Inferred relationship | Some | ||
| Abrilada 40 mg/0.8 mL injection, 0.8 mL pen device | Is a | adalimumab 40 mg/0.8 mL injection, 0.8 mL pen device | true | Inferred relationship | Some | ||
| Abrilada 40 mg/0.8 mL injection, 0.8 mL pen device | has TP | Abrilada | true | Inferred relationship | Some | ||
| Abrilada 40 mg/0.8 mL injection, 0.8 mL pen device | has TPUU | Abrilada 40 mg/0.8 mL injection, 0.8 mL pen device | true | Inferred relationship | Some | 582020882 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Abrilada 40 mg/0.8 mL injection, 0.8 mL pen device | Is a | True | Abrilada 40 mg/0.8 mL injection, 0.8 mL pen device | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR